SLDB
Solid Biosciences Inc.Company with tickers: SLDB
Market Cap
$910.66M
Shares Outstanding
98,449,606
CIK
1707502
CUSIP
83422E204
13F Activity (30d)
7 filings
5 filers
Website
Visit website
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-10 | Keresty Georgia |
Director | Award | 77,500 |
| 2026-06-10 | Freed Martin I |
Director | Award | 77,500 |
| 2026-06-10 | SMITH IAN F |
Director, Chief Executive Officer | Award | 77,500 |
| 2026-06-10 | Sullivan Lynne Marie |
Director | Award | 77,500 |
| 2026-06-10 | Stone Adam Leo |
Director | Award | 77,500 |
| 2026-06-10 | Kahn Clare |
Director | Award | 77,500 |
| 2026-06-10 | Nagendran Sukumar |
Director, President and Head of R&D | Award | 77,500 |
| 2026-06-10 | PERCEPTIVE ADVISORS LLC |
10% Owner | Award | 77,500 |
| 2026-06-10 | Ganot Ilan |
Director | Award | 77,500 |
| 2026-04-02 | SMITH IAN F |
Director, Chief Executive Officer | Convert | 3,441 |
| 2026-04-02 | SMITH IAN F |
Director, Chief Executive Officer | Convert | 3,441 |
| 2026-03-09 | PERCEPTIVE ADVISORS LLC |
10% Owner | Award | 8,912,655 |
| 2026-02-18 | Brooks Gabriel |
Chief Medical Officer | Sell | 0 |
| 2026-02-18 | Herzich Paul |
Chief Technology Officer | Sell | 3,616 |
| 2026-02-18 | Hanrahan Jessie |
Chief Regulatory Officer | Sell | 4,134 |
| 2026-02-18 | Tan Kevin |
Chief Financial Officer | Sell | 5,404 |
| 2026-02-18 | Cumbo Alexander |
Director | Sell | 16,644 |
| 2026-02-18 | Howton David T |
Chief Operating Officer | Sell | 7,469 |
| 2026-02-18 | Ganot Ilan |
Director | Sell | 2,658 |
| 2026-02-13 | Tan Kevin |
Chief Financial Officer | Convert | 10,625 |
| 2026-02-13 | Tan Kevin |
Chief Financial Officer | Convert | 10,625 |
| 2026-02-13 | Cumbo Alexander |
Director | Convert | 30,031 |
| 2026-02-13 | Hanrahan Jessie |
Chief Regulatory Officer | Convert | 8,125 |
| 2026-02-13 | Ganot Ilan |
Director | Convert | 4,861 |
| 2026-02-13 | Brooks Gabriel |
Chief Medical Officer | Convert | 10,937 |
| 2026-02-13 | Herzich Paul |
Chief Technology Officer | Convert | 7,187 |
| 2026-02-13 | Herzich Paul |
Chief Technology Officer | Convert | 7,187 |
| 2026-02-13 | Cumbo Alexander |
Director | Convert | 30,031 |
| 2026-02-13 | Hanrahan Jessie |
Chief Regulatory Officer | Convert | 8,125 |
| 2026-02-13 | Ganot Ilan |
Director | Convert | 4,861 |
| 2026-02-13 | Howton David T |
Chief Operating Officer | Convert | 14,687 |
| 2026-02-13 | Howton David T |
Chief Operating Officer | Convert | 14,687 |
| 2026-02-13 | Brooks Gabriel |
Chief Medical Officer | Convert | 10,937 |
| 2026-02-04 | Herzich Paul |
Chief Technology Officer | Sell | 10,905 |
| 2026-02-04 | Howton David T |
Chief Operating Officer | Sell | 18,894 |
| 2026-02-04 | Tan Kevin |
Chief Financial Officer | Sell | 14,783 |
| 2026-02-04 | Hanrahan Jessie |
Chief Regulatory Officer | Sell | 12,348 |
| 2026-02-04 | Brooks Gabriel |
Chief Medical Officer | Sell | 12,616 |
| 2026-02-04 | Ganot Ilan |
Director | Sell | 7,205 |
| 2026-02-04 | Cumbo Alexander |
Director | Sell | 48,913 |
| 2026-02-02 | Cumbo Alexander |
Director | Sell | 80,258 |
| 2026-02-02 | Brooks Gabriel |
Chief Medical Officer | Sell | 28,335 |
| 2026-02-02 | Howton David T |
Chief Operating Officer | Sell | 37,771 |
| 2026-02-02 | Tan Kevin |
Chief Financial Officer | Sell | 26,837 |
| 2026-02-02 | Hanrahan Jessie |
Chief Regulatory Officer | Sell | 26,535 |
| 2026-02-02 | Herzich Paul |
Chief Technology Officer | Sell | 26,250 |
| 2026-01-31 | Tan Kevin |
Chief Financial Officer | Convert | 33,075 |
| 2026-01-31 | Hanrahan Jessie |
Chief Regulatory Officer | Convert | 27,625 |
| 2026-01-31 | Ganot Ilan |
Director | Convert | 15,000 |
| 2026-01-31 | Herzich Paul |
Chief Technology Officer | Convert | 24,675 |
Showing 1–50 of 513 transactions